Delivery Order SPE2DB24D8001-SPE2DB25FLAGN
Award Date 8/20/25
Potential Completion Date 8/21/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, received a delivery order award from the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jardiance 25 mg tablets (90-count). This firm fixed-price delivery order, valued at $1,184.05, is expected to be completed by July 31, 2025, and represents performance at the vendor's Anoka, Minnesota location. The award carries no set-aside designation and operates under Dakota Drug's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,426.86 to Dakota Drug, Inc. for the supply of Jardiance 25 mg tablets (90-count units) with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a non-set-aside procurement executed through Dakota Drug's existing Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program. The contract is valued at up to $999,999,999.00 and runs through...
- The Defense Logistics Agency awarded a $1,391.42 firm fixed-price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of 90 tablets of Jardiance 25 mg. The award, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, carries no set-aside designation. This delivery order is issued under Dakota Drug, Inc.'s larger single-award Indefinite Delivery Contract (SPE2DB24D8001) valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $2.74K delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Jardiance 25 mg tablets (90-count units). Issued on August 19, 2025, with completion scheduled for August 20, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract contains no...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $11,094.61 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Jardiance 25 mg tablets. This award is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999.00, which allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to...
- The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,204.90 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Jardiance 10 mg tablets. This contract, which has a performance period ending on May 10, 2023, is part of the DLA Troop Support Medical's ECAT Generation V Program, a significant Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 that allows Dakota Drug, Inc. to supply a wide...
- The Defense Logistics Agency awarded a delivery order valued at $1,985.04 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, on August 21, 2025. The order covers 90 tablets of Jardiance 25 mg, a diabetes management medication, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a continuation of Dakota Drug's pharmaceutical supply support to the federal government. This...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4,566,188 units of the pharmaceutical product JARDIANCE 10 MG TABLET 90S. The contract, valued at $10,284.01, has an ultimate completion date of October 24, 2024. This award is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide Jardiance 10 mg tablets. The contract, valued at $9,269.99, has an ultimate completion date of August 6, 2024. This award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which allows the company to supply a range of pharmaceutical products, medical...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,565,231,498 units of Jardiance 10 MG Tablet 90s medication. The contract has a ceiling value of $3,643.63 and a period of performance through July 24, 2024. This order is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...